LYRA: Lyra Therapeutics Inc

LYRA News

• 20:43 Lyra Therapeutics receives Nasdaq notice for non-compliance with equity requirement
• 21:15 Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates
• 20:13 Lyra earnings missed by $5.34, revenue fell short of estimates
• 12:55 Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates
• 01:35 Lyra Therapeutics CEO Palasis sells $13944 in stock
• 01:31 Lyra Therapeutics CFO Cavalier sells $6k in shares
• 12:08 Lyra Therapeutics raises $5 million in registered direct offering
• 20:14 Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst
• 10:52 H.C. Wainwright lifts Lyra Therapeutics stock target to $16
• 02:41 APLD, META, GOOGL, LYRA, TSLA: 5 Trending Stocks Today - Alphabet (NASDAQ:GOOG), Applied Digital (NASDAQ:APLD)
• 22:58 Morning News Wrap-Up: Monday’s Biggest Stock Market Stories - TipRanks.com
• 20:30 U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.08%
• 20:12 Lyra Therapeutics Stock (LYRA) Rockets 530% on Phase 3 Trial Results - TipRanks.com
• 16:49 Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May - Applied Digital (NASDAQ:APLD), Lyra Therapeutics (NASDAQ:LYRA)
• 15:00 Lyra Therapeutics Shares Climb Over 500% After Major CRS Trial Win
• 14:16 Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings - The Campbell's (NASDAQ:CPB), InMed Pharmaceuticals (NASDAQ:INM)
• 13:33 Lyra Therapeutics stock hits 52-week high at $28.66
• 12:29 Why Is Lyra Therapeutics Stock Surging Over 400% On Monday? - Lyra Therapeutics (NASDAQ:LYRA)
• 11:16 Lyra Therapeutics stock soars on positive Phase 3 trial results
• 11:05 Lyra Therapeutics reports positive phase 3 trial results for CRS treatment
• 20:30 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.58%
• 23:20 Upcoming Stock Splits This Week (May 27 to May 30) – Stay Invested - TipRanks.com
• 10:25 US Stocks Likely To Open Lower After S&P 500's Six-Day Streak: 'Quick Recoveries Tend To See Stocks Rally More Over The Next 3-12 Months,' Says Expert - ASP Isotopes (NASDAQ:ASPI)